Autophagy is a cardinal cellular mechanism that involves the degradation and digestion of intracellular constituents by lysosomes [1] [2] [3] . Autophagy controls inflammation through interactions with immune signaling pathways and regulates the secretion of molecular mediators of inflammation [4] [5] [6] . Autophagy plays a vital role in the physiological conditions of many immune cells including macrophages [7] [8] [9] . Appropriate autophagy contributes to neuroprotection, whereas inappropriate autophagy could induce cell death [10] [11] [12] . Autophagy constitutes a lysosome-mediated degradation process [13] and is crucial for the maintenance of metabolic homeostasis by inhibiting the accumulation of misfolded proteins and of damaged cytoplasmic organelles [14] [15] [16] . Autophagy mitigates neurodegeneration caused by oxidative stress [17] , whereas impaired autophagy signaling has been implicated in neurodegenerative disorders such as Parkinson' s, Alzheimer' s diseases [18] [19] [20] [21] , spinal cord injury [22] , and stroke [23] .
INTRODUCTION
Autophagy is a cardinal cellular mechanism that involves the degradation and digestion of intracellular constituents by lysosomes [1] [2] [3] . Autophagy controls inflammation through interactions with immune signaling pathways and regulates the secretion of molecular mediators of inflammation [4] [5] [6] . Autophagy plays a vital role in the physiological conditions of many immune cells including macrophages [7] [8] [9] . Appropriate autophagy contributes to neuroprotection, whereas inappropriate autophagy could induce cell death [10] [11] [12] . Autophagy constitutes a lysosome-mediated degradation process [13] and is crucial for the maintenance of metabolic homeostasis by inhibiting the accumulation of misfolded proteins and of damaged cytoplasmic organelles [14] [15] [16] . Autophagy mitigates neurodegeneration caused by oxidative stress [17] , whereas impaired autophagy signaling has been implicated in neurodegenerative disorders such as Parkinson' s, Alzheimer' s diseases [18] [19] [20] [21] , spinal cord injury [22] , and stroke [23] .
Autophagosome formation is controlled by protein complexes including the mammalian target of rapamycin (mTOR) complex 1 (mTORC1) and the coiled-coil myosin-like BCL2-interacting protein 1 (Beclin 1)-complex [24] [25] [26] [27] . The autophagy process is initiated by the regulation of protein complexes composed of more than 30 autophagy-related (ATG) proteins [28] [29] [30] and autophagic adaptor light chain 3 protein (LC3) [31] . The phosphatidylethanol-amine-conjugated LC3 (LC3II) is localized at the inner and outer autophagosomal membranes and plays a critical role for the initiation of autophagy process [31] . Autophagy can regulate the production and secretion of diverse cytokines in cells [32] [33] [34] in Alzheimer' s disease [35] . The decreased level of Beclin 1 and the blockade of microglial pahgocytosis were observed in Alzheimer' s disease patients [36, 37] . Several microRNA (miR) are associated with autophagic flux [38] . The overexpression of miR-195 [39] , miR-14 [40] , miRNA-30a [41] and miR-423-5p [42] promote induction of autophagy, whereas suppression of miR-101 induces autophagy in cardiomyocytes [43] . MicroRNA-Let7A (miR-Let7A) is a tumor suppressor miRNA that target transcription-related genes in apoptosis [44] . MiR-Let7A regulates anti-inflammatory responses through repression of specific genes acting in downstream signaling pathways [44] and is involved in the function of microglia in inflammatory injury. Notably, miR-Let7 promotes autophagy by suppression of mTOR signaling [45] , and activates the neuronal autophagy in the brain of mice [46, 47] . Moreover, the suppression of miR-Let7a in mice leads to the reduction of LC3 II levels [45] . In the present study, we investigated whether miR-Let7a controls autophagy process in microglia activated by lipopolysaccharide (LPS).
MATERIALS AND METHODS

BV2 microglia culture
BV2 microglial cells were obtained from Prof. Eun-hye Joe (Ajou University School of Medicine, Chronic Inflammatory Disease Research Center). BV2 cells cultured in Dulbecco' s Modified Eagle' s Medium (Gibco, NY, USA) supplemented with 10% fetal bovine serum (Gibco, NY, USA) and 100 μg/ml penicillin-streptomycin (Gibco, NY, USA) at 37°C in a humidified atmosphere containing 5% CO 2 . Lipopolysaccharide (LPS, 1 μg/ml; Sigma-Aldrich, St. Louis, MO, USA) was treated in BV2 microglia for 12 h before sampling.
miR-Let7A transfection
Mmu-Let7A-5p (cat#, 4464066) was purchased from Ambion (Ambion, Austin, TX, USA). For the transfection of RNA duplexes, miR-Let7A mimic or miR-Let7A inhibitor was diluted to a 20 nM final concentration in Opti-MEM, and mixed with Lipofectamine 2000 (Invitrogen, Carlsbad, CA, USA). After incubation at room temperature for 15 min, the mixture was added to cells. Cells were incubated for 72 h and harvested for total protein or RNA extraction.
Reverse transcription PCR
Reverse transcription PCR was performed to measure mRNA levels of Beclin-1, LC3II in BV2 microglia. Briefly, cells were lysed with Trizol reagent (Invitrogen, Carlsbad, CA, USA), and total RNA was extracted according to the manufacturer' s . PCR products were electrophoresed in 1.5% agarose gels and stained with ethidium bromide as described [48] .
Western blot analysis
BV2 microglia were washed rapidly with ice-cold PBS, scraped, and collected. Cell pellets were lysed with ice-cold RIPA buffer (Sigma-Aldrich, St. Louis, MO, USA). The lysates were centrifuged at 12,000 rpm for 30 min at 4 o C to produce whole-cell extracts.
Protein content was quantified using the BCA method (Pierce, Rockford, IL, USA [49] .
Immunocytochemistry
The expression of Beclin1 and ATG3 in BV2 cells was examined by immunocytochemistry. Cells in all experimental groups were washed three times with PBS, fixed with 4% paraformaldehyde for 3 h, and then washed with PBS. BV2 cells were permeabilized with 0.025% Triton X-100 and blocked for 1 h at room temperature with dilution buffer (Invitrogen, Carlsbad, CA, USA). Primary antibodies, anti-rabbit-Beclin1 (1 : 500, Santa Cruz, CA, USA), and anti-rabbit-ATG3 (1 : 500, Santa Cruz, CA, USA) were prepared in dilution buffer, added to samples, and incubated for 3 h at room temperature. Primary antibody was then removed, and cells were washed 3 times for 3 min each with PBS. Next, samples were incubated with Rhodamine-conjugated goat anti-rabbit (1 : 200, Jackson Immunoresearch) for 1 h 30 min at room temperature. Cells were washed again three times for 3 min each with PBS and stained with 1 μg/mL 4',6-diamidino-2-phenylindole (DAPI) (1 : 100, Invitrogen, Carlsbad, CA, USA) for 15 min at room temperature. Fixed samples were imaged using a Zeiss LSM 700 confocal microscope (Carl Zeiss, Thornwood, NY, USA) [49] .
Statistical analysis
Statistical analyses were carried out using SPSS 18.0 software (IBM Corp., Armonk, NY, USA). All data are expressed as mean±S. E.M. Significant intergroup differences were determined by oneway analysis of variance (ANOVA) followed by Bonferroni post hoc multiple comparison test. Each experiment included at least 3 replicates per condition. Differences were considered significant at *p<0.05, **p<0.001. 
Role of miR-Let7A in Microglia
RESULTS
The mRNA levels of LC3II in microglia were increased after miR-Let7A overexpression LC3II (the microtubule-associated protein light chain 3) is the key element in the initial isolation membrane nucleation of autophagy process [50] . PCR analysis showed that the mRNA level of LC3II was increased in miR-Let7A-overexpressing BV2 cells (Fig. 1A) . Western blot analysis confirmed that the protein level of LC3II in miR-Let7A-overexpressing BV2 cells was increased comparison to the normal group (Fig. 1B) .
The overexpression of miR-Let7A modulated the expression of Beclin1 and ATG3 in inflammation-induced microglia
The expression levels of Beclin 1 transcripts (Fig. 2) and Beclin 1 protein (Fig. 3A) were slightly reduced in miR-Let7A-overexpressing BV2 cells compared to those in normal BV2 cells. LPS-treated BV2 cells showed more profound reduction of Beclin 1 transcripts and Beclin 1 protein (Fig. 2 and 3A) . The miR-Let7A overexpression partially blocked reduced expression of Beclin 1 transcripts and Beclin 1 protein in LPS-treated BV2 cells (Fig. 2 and 3A).
The ATG3 level was increased in miR-Let7A-overexpressing BV2 cells, whereas the ATG3 level was decreased in LPS-treated BV2 cells compared to that in normal BV2 cells (Fig. 3B) . In LPStreated miR-Let7A-overexpressing BV2 cells, the ATG3 level was lower than that in normal BV2 cells, but it was higher than that in LPS-treated BV2 cells (Fig. 3B) .
The LC3II level was increased in miR-Let7A-overexpressing BV2 cells, whereas the LC3II was not significantly changed (Fig.  3C) . In LPS-treated miR-Let7A-overexpressing BV2 cells, LC3II level was higher than that in normal BV2 cells (Fig. 3C) .
Immunocytochemical analyses were performed to visualize the miR-Let7A-dependent regulation of ATG3 (Fig. 4) and Beclin 1 (Fig. 5) expressions in a cellular level. The miR-Let7A overexpression in BV2 cells increased the expression of ATG3, whereas LPS treatment suppressed ATG3 in BV2 cells (Fig. 4A) . Overexpression of miR-Let7A partially recovered LPS-induced reduced expression of ATG3 (Fig. 4B) . The overexpression of miRLet7A in LPS-stimulated BV2 cells also partially recovered LPSinduced reduced expression of Beclin 1 (Fig. 5B) .
Considering that Beclin1 is crucial in the initiation and 
DISCUSSION
Autophagy is an essential mechanism in degrading dysfunctional proteins and damaged mitochondria in cells [29, [53] [54] [55] [56] [57] . Autophagy regulates inflammatory responses [58, 59] . On the other hand, impairment in autophagy is harmful; it aggravates endoplasmic reticulum (ER) stress in cells [14, 57, 60] and is associated with neurodegeneration such as Alzheimer' s disease [61] [62] [63] . Microtubule-associated protein LC3II is located on the internal surface of autophagosomes [14] . Several studies suggest that upregulation of LC3II increases the autophagic flux and early autophagosome formation, which requires also Beclin 1 [64, 65] . LC3II levels are reduced in the brain of anti-miR-Let7 treated Huntington' s disease mice [45] . These results, together with miRLet7-dependent induction of LC3II in BV2 cells (Fig. 3) , support the notion that miR-Let7A plays a role in autophagy induction in microglia.
Numerous studies have reported that Beclin1 is a key factor in the activation of the autophagy [51, 52] and the initiation of autophagy by enhancing vesicle nucleation [66] . A pivotal role of Beclin1 in regulating autophagy in microglia has been described [67] . Considering that Beclin 1 is essential in autophagy [51, 52] , we speculate that miR-Let7A may boost the initiation and activation of microglial autophagy by up-regulating Beclin 1 against inflammatory stress. ATG3 is a component of autophagy-related ubiquitination-like systems [24] and functions as a regulator of cell survival [68] by generating the autophagic vesicle [53, 69, 70] . miR-Let7A partially increased ATG3 expression in LPS-treated BV2 cells (Fig. 3B) . This result suggests that miR-Let7A promotes autophagy in microglia via up-regulating ATG3.
Disruption of autophagy flux contributes to neuronal cell death in Alzherimer' s disease and Huntington disease [71, 72] . Considering that several autophagic factors including LC3II, Beclin1, and ATG3 were regulated by miR-Let7A in activating microglia, miR-Let7A-depdent regulation of microglial autophagy needs be studied in more detail in the context and neuroinflammation and neurodegeneration.
